What move does the options market price into Ionis Pharmaceuticals's report?

Implied ±7.4%, either direction.

IONSNasdaqPharmaceutical Preparations

Ionis Pharmaceuticals Inc (IONS) earnings date, market-implied expected move, and options open interest by expiry

40.43

−0.81 · −1.97%

post 40.43 0.00%

After hours16:00 ETdelayed

Open41.24Volume2.6MMkt cap$6.9BEPS-3.48

Day40.43 – 41.650%52-wk41.19 – 86.740%

IONS

Ionis Pharmaceuticals Inc

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

Inputs

±7.4%implied · report alone

38.0844.17

straddle ±10.2%

spot 41.13exp Nov 20ATM strike 40ATM straddle 4.92IV 71%

Nov 3 closereport share · term structure

Expected move

Inputs

Next report

Nov 4

before open · in 1 day

est.Q3 FY26

Calendar

Next report

Last report

−2.28%

shaded = implied · ▲▼ = realized

Jul 29 '26 · confirmed

Implied vs realized

Linked news

8hPTCT · customerPTC Therapeutics authorizes $500.0 million share repurchase program
1dNVS · customerBioArctic collaborator Novartis terminates agreement
1dGSK · customerGSK total voting rights 4,045,439,182

News

Largest filed tie

13F top-10 QoQ

+3.23%

shares held · 10 largest managers

13F · Jun 30 '26126d lag

517 managers

Top fund weight

1.00%

IONS weight · XBI

N-PORTJun 30 '26

4 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Ionis Pharmaceuticals (IONS) is expected to report on Nov 4 before open (estimated date).

Implied vs realized

1 report

—≥ implied

Q2 FY26Jul 29 '26confirmed—▼−2.28%—

quarterimplied−5%0+5%realized×

Q2 FY26—▼−2.28%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 4 expiries · Nov 2 close

0.54OI · 4 expiries · Nov 2 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

3,418+80%Nov 2017d6,353+9%

1,2400%Dec 1845d0.841,469+2%0.84

7,5450%Jan 1573d0.4417,268+1%0.44

763+131%Apr 16164d1.00765+91%1.00

ExpiryPutsCallsP/C

Nov 2017d3,418+80%6,353+9%0.54

Dec 1845d1,2400%1,469+2%0.84

Jan 1573d7,5450%17,268+1%0.44

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

scenario · straddle±10.2%

Funds 4

XBI±0.1%

VTI±0.0%

VT±0.0%

REVS±0.0%

Dashed = straddleMethod Source: SEC filings · N-PORT · market data

Linked exposure

Revenue flow

as filedQ2 FY26

−42.79%as filednet margin · revenue +8.88% QoQ · −40.73% YoY

Revenue$268M+8.88%

Gross profit$265M98.98%+9.09%

Operating income−$102M−38.18%+12.89%

Pre-tax income−$113M−22.83%

Net income−$115M−42.79%−23.90%

Cost of revenue$3M−8.18%

Operating expenses$368M+1.93%

Tax$1M+479.82%

Other expense−$11M−144.15%

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Long dash = implied range · Nov 3 close · Hatch = extended hours · ▯ up · ▮ downSource: market data · 16:00 ET

Intraday

Event sensitivity

FOMC ×1.25· ±2.3% vs ±1.8% · 24 releases

eventrelease day|move|up · n×base

FOMCrate decision±2.3%11 of 24×1.25

CPIconsumer prices±1.8%3 of 10×0.97

PCEpersonal income & outlays±1.6%10 of 19×0.88

GDPgross domestic product±1.6%9 of 19×0.87

CPROFcorporate profits±1.6%6 of 12×0.86

NFPjobs report±1.4%3 of 10×0.78

PPIproducer prices±1.1%4 of 10×0.62

Bar = avg |move| to ±3% · tick = ±1.8% avg day · ×base = |move| ÷ ±1.8% · min 6 releases

Earnings history

EPS -0.69 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Jul 29 '26 · confirmed	-0.69	—
Q1 FY26	—	-0.56	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod